To include your compound in the COVID-19 Resource Center, submit it here.

PEG-Intron and Rebetol ribavirin regulatory update

ENZN partner Schering-Plough Corp. (SGP, Kenilworth, N.J.) received U.S. Patent

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE